Osteoporosis Drugs Linked to a Rare Form of Fracture

Prolonged use of bisphosphonates raises the risk of side effects.

Bisphosphonate drugs, such as alendronate (Fosamax), ibandronate (Boniva) and zoledronic acid (Reclast), are proven to combat bone loss and fractures in people with the bone-thinning disease osteoporosis. However, prolonged use of the drugs can alter the composition of bone, making it more brittle—and vulnerable to a rare but serious form of fracture. Now a new […]

Comments

Leave a Reply

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×